
Dwight Capital (via Dwight Mortgage Trust) closed $590M in real estate financings in June, including a $183M construction loan for a 530-unit luxury multifamily project in Gilroy, CA. The $183M facility—Dwight’s largest construction loan to date—will fund development across four mid-rise buildings and 33 townhomes at 315 Las Animas Avenue. Overall, the update signals strong origination momentum for the platform during the month.
This reads more like a credit-channel signal than a housing-demand signal. The important takeaway is that private capital is still willing to fund large multifamily starts for top-tier sponsors, which supports originators and high-yield CRE lenders, but it also keeps new supply coming in markets where apartment rent growth is already fragile. Over 6-18 months, that is a quiet headwind for West Coast apartment owners because the incremental units compete into a softer affordability backdrop rather than into a clean demand upswing.
The bigger second-order risk is refinancing. Construction loans look attractive today if they can be taken out at completion, but the real test is 24-36 months later when cap rates, debt costs, and lease-up assumptions have to line up. If long rates stay sticky, the same lending appetite that boosts near-term volume can turn into credit impairment later, so this is constructive for well-capitalized lenders and much less so for leveraged balance-sheet players.
Contrarianly, the market may misread this as bullish proof of housing strength when it is really evidence that capital is still chasing yield in luxury product. That argues for fading overexposure to apartment REITs with meaningful California or supply-heavy market exposure, while keeping an eye on bank CRE underwriting standards and multifamily delinquency trends. The thesis breaks if financing dries up, 10-year yields fall sharply, or multifamily starts/permits roll over enough to choke the supply pipeline.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialOverall Sentiment
mildly positive
Sentiment Score
0.12
Ticker Sentiment